LLY Eli Lilly and Company
P/E
40.32
Forward P/E
31.25
Price/Sales
13.98
Beta
0.517
Div Yield
0.0054%
Market Cap
--
Company Analysis
Latest News
Eli Lilly and Partner Roche Gain FDA Approval for Alzheimer's Blood Test
Eli Lilly and Company, in partnership with Roche, has received clearance from the U.S. Food and Drug Administration (FDA) for their blood test designed to aid...
Eli Lilly to Invest Over $1 Billion in India to Expand Manufacturing and Supply Chain
Eli Lilly and Company announced on October 6, 2025, a significant investment of over $1 billion into new contract manufacturing in India. The investment...
Eli Lilly to Invest Over $1 Billion in Indian Manufacturing Partnerships
Eli Lilly and Company announced it will invest over $1 billion in contract manufacturing partnerships in India to increase the global supply of its drugs for...